UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | I | J | K | L | M | N | P | Q | R | S | T | W | Y | Z
Number of items: 173.

A

Adams, VC; Hunt, JR; Rosa Brunet, L; Rook, GAW; (2002) Effect of Mycobacterium vaccae on ICOS expression in a murine model. In: Immunology. (pp. 111 - 111).

Ahmed, SM; Al, H; Reid, WM; Johnson, MA; Poulter, LW; (2002) The cellular response associated with cervical intraepithelial neoplasia in HIV+ and HIV- subjects. Scandinavian Journal of Immunology , 56 (2) 204 - 211.

Ahn, JW; Powell, KL; Kellam, P; Alba, MM; (2002) Gammaherpesvirus lytic gene expression as characterised by DNA array. Journal of Virology , 76 (12) 6244 - 6256.

Andersson, J; Kinloch, S; Sonnerborg, A; Nilsson, J; Fehniger, TE; Spetz, AL; ... Perrin, L; + view all (2002) Low levels of perforin in CD8+ T lymphocytes in lymphoid tissue during acute human immunodeficiency virus type 1 infection. The Journal of Infectious Diseases , 185 1355 - 1358.

Arriaga, AK; Orozco, EH; Aguilar, LD; Rook, GAW; Pando, RH; (2002) Immunological and pathological comparative analysis between experimental latent tuberculous infection and progressive pulmonary tuberculosis. CLIN EXP IMMUNOL , 128 (2) 229 - 237.

B

Barry, SM; Condez, A; Johnson, MA; Janossy, G; (2002) Determination of bronchoalveolar lavage leukocyte populations by flow cytometry in patients investigated for respiratory disease-. CYTOMETRY , 50 (6) 291 - 297.

Barry, SM; Lipman, MC; Deery, A; Johnson, MA; Janossy, G; (2002) Immune reconstruction pneumonitis following Pneumocystis carinii pneumonia in HIV-infected subjects. HIV Medicine , 3 (3) 207 - 211.

Bartosch, B; Weiss, RA; Takeuchi, Y; (2002) PCR-based cloning and immunocytological titration of infectious porcine endogenous retrovirus subgroup A and B. J GEN VIROL , 83 2231 - 2240.

Besnier, C; Takeuchi, Y; Towers, G; (2002) Restriction of lentivirus in monkeys. P NATL ACAD SCI USA , 99 (18) 11920 - 11925. 10.1073/pnas.172384599.

Besnier, C.; Takeuchi, Y.; Towers, G.; (2002) Restriction of lentivirus in monkeys. Proceedings of the National Academy of Sciences , 99 (18) pp. 11920-11925. 10.1073/pnas.172384599.

Bodman-Smith, MD; Williams, I; Johnstone, R; Boylston, A; Lydyard, PM; Zumla, A; (2002) T cell receptor usage in patients with non-progressing HIV infection. CLIN EXP IMMUNOL , 130 (1) 115 - 120.

Boshoff, C; Weiss, RA; (2002) AIDS-related malignancies. Nature Reviews Cancer , 2 373 - 382.

Breivik, T; Rook, GAW; (2002) Treatment with SRL172 (heat-killed Mycobacterium vaccae) inhibits progression of established experimental periodontal disease in Wistar rats. J PERIODONTAL RES , 37 (3) 210 - 214.

Brett, PJ; Tiwana, H; Feavers, IM; Charalambous, BM; (2002) Characterization of oligopeptides that cross-react with carbohydrate-specific antibodies by real time kinetics, in-solution competition enzyme-linked immunosorbent assay, and immunological analyses. J BIOL CHEM , 277 (23) 20468 - 20476. 10.1074/jbc.M200387200. Gold open access

Breuer, J; (2002) Studies on shingles, is the virus ordinary chickenpox virus? REV MED VIROL , 12 (1) 5 - 6.

Breuer, J; (2002) Vaccination to prevent varicella and shingles - Author's reply. J CLIN PATHOL , 55 (5) 399 - 399.

Brunet, LR; Hunt, J; Rook, GAW; (2002) Dangers of therapeutic manipulation of the Th1-Th2 balance. TRENDS IMMUNOL , 23 (3) 127 - 128.

C

Cepeda, JA; Hayman, SJ; Kibbler, C; Wilson, APR; (2002) In vitro susceptibility of Gram-positive cocci to linezolid and teicoplanin: twelve month use of linezolid for Gram-positive infections in ICU. In: (Proceedings) European Congress of Chemotherapy. : Paris.

Cepeda, JA; Hayman, SJ; Kibbler, C; Wilson, APR; (2002) In vitro susceptibility of Gram-positive cocci to linezolid and teicoplanin: use of linezolid for Gram-positive infections in ICU. In: European Congress of Chemotherapy.

Cepeda, JA; Whitehouse, T; Cooper, B; Hails, J; Hayman, SJ; Jones, K; ... Wilson, APR; + view all (2002) Linezolid versus teicoplanin in the treatment of Gram positive infections in the critically ill: a randomized, double-blind, multicentre study. In: (Proceedings) 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). : San Diego.

Cepeda, JA; Whitehouse, T; Tobin, C; Zhang, J; MacGowan, A; Kibbler, C; ... Singer, M; + view all (2002) The Pharmacokinetic Profiles of Linezolid and Teicoplanin in the critically ill. In: European Congress of Chemotherapy.

Cepeda, JA; Whitehouse, T; Tobin, C; Zhang, J; MacGowan, A; Kibbler, C; ... Singer, M; + view all (2002) The Pharmacokinetic Profiles of Linezolid and Teicoplanin in the critically ill. In: (Proceedings) European Congress of Chemotherapy. : Paris.

Cepeda, JA; Whitehouse, T; Wilson, APR; Singer, M; Bellingan, G; Kibbler, C; Shaw, S; (2002) MRSA clearance during treatment with linezolid. In: (Proceedings) European Congress of Chemotherapy.

Charalambous, BM; (2002) Meningitis B vaccine. PCT/GB.

Chintu, C; Mudenda, V; Lucas, S; Nunn, A; Lishimpi, K; Maswahu, D; ... UNZA-UCLMS Project Paediat Post-Mo,; + view all (2002) Lung diseases at necropsy in African children dying from respiratory illnesses: a descriptive necropsy study. LANCET , 360 (9338) 985 - 990.

Cochrane, A; Searle, B; Hardie, A; Robertson, R; Delahooke, T; Cameron, S; ... Simmonds, P; + view all (2002) A genetic analysis of hepatitis Cvirus transmission between injection drug users. JOURNAL OF INFECTIOUS DISEASES , 186 (9) 1212 - 1221.

Cooke, FJ; Sabin, CA; Zuckerman, JN; (2002) Impact of the insect biting nuisance on a British youth expedition to Alaska. J TRAVEL MED , 9 (2) 76 - 81.

D

Deayton, JR; Sabin, CA; Britt, WB; Jones, IM; Wilson, P; Johnson, MA; ... Emery, VC; + view all (2002) Rapid reconstitution of humoral immunity against cytomegalovirus but not HIV following highly active antiretroviral therapy. AIDS , 16 (16) 2129 - 2135.

Dimmic, MW; Rest, JS; Mindell, DP; Goldstein, RA; (2002) rtREV: An amino acid substitution matrix for inference of retrovirus and reverse transcriptase phylogeny. JOURNAL OF MOLECULAR EVOLUTION , 55 (1) 65 - 73. 10.1007/s00236-001-2304-y.

Dimmic, MW; Rest, JS; Mindell, DP; Goldstein, RA; (2002) rtREV: an amino acid substitution matrix for inference of retrovirus and reverse transcriptase phylogeny. J Mol Evol , 55 (1) 65 - 73. 10.1007/s00239-001-2304-y.

Donaldson, IJ; Shefta, J; Lawson, CA; Bushnell, JR; Morgan, AW; Isaacs, JD; ... Boylston, AW; + view all (2002) Unique TCR beta-subunit variable gene haplotypes in Africans. Immunogenetics , 53 (10-11) 884 - 893. 10.1007/s00251-001-0406-8.

Druilhe, P; Hagan, P; Rook, GAW; (2002) The importance of models of infection in the study of disease resistance. TRENDS MICROBIOL , 10 (10) S38 - S46.

E

Elsaghier, AAF; Aucken, HM; Hamilton-Miller, JM; Shaw, S; Kibbler, CC; (2002) Resistance to teicoplanin developing during treatment of methicillin-resistant Staphylococcus aureus infection. J ANTIMICROB CHEMOTH , 49 (2) 423 - 424.

Emery, VC; Hassan-Walker, AF; (2002) Focus on new drugs in development against human cytomegalovirus. DRUGS , 62 (13) 1853 - 1858.

Emery, VC; Hassan-Walker, AF; Burroughs, AK; Griffiths, PD; (2002) Human cytomegalovirus (HCMV) replication dynamics in HCMV-naive and -experienced immunocompromised hosts. J INFECT DIS , 185 (12) 1723 - 1728. Green open access
file

F

Ferns, RB; Fletcher, H; Bradley, S; Mackinnon, S; Hunt, C; Tedder, RS; (2002) The prospective evaluation of a nested polymerase chain reaction assay for the early detection of Aspergillus infection in patients with leukaemia or undergoing allograft treatment. BRIT J HAEMATOL , 119 (3) 720 - 725.

Fiddian, P; Sabin, CA; Griffiths, PD; (2002) Valacyclovir provides optimum acyclovir exposure for prevention of cytomegalovirus and related outcomes after organ transplantation. JOURNAL OF INFECTIOUS DISEASES , 186 S110 - S115.

G

Gandy, M; Zumla, A; (2002) The resurgence of disease: social and historical perspectives on the 'new' tuberculosis. SOC SCI MED , 55 (3) 385 - 396.

Gandy, M; Zumla, A; (2002) Theorizing tuberculosis: a reply to Porter and Ogden. SOC SCI MED , 55 (3) 399 - 401.

Garson, J; Aggarwal, A; Sarkar, S; (2002) Birds as surrogates for biodiversity: an analysis of a data set from southern Quebec. J.Biosci. , 27 (4 Suppl 2) 347 - 360.

Gibb, DM; Walker, AS; Kaye, S; De Rossi, A; Ait-Khaled, M; Pillay, D; ... Babiker, AG; + view all (2002) Evolution of antiretroviral phenotypic and genotypic drug resistance in antiretroviral-naive HIV-1-infected children treated with abacavir/lamivudine, zidovudine/lamivudine or abacavir/zidovudine, with or without nelfinavir (the PENTA 5 trial). Antiviral Therapy , 7 (4) 293 - 303.

Gilbert, N; Corden, S; Ijaz, S; Grant, PR; Tedder, RS; Boxall, EH; (2002) Comparison of commercial assays for the quantification of HBV DNA load in health care workers: calibration differences. J VIROL METHODS , 100 (1-2) 37 - 47.

Gillespie, SH; (2002) Evolution of drug resistance in Mycobacterium tuberculosis: Clinical and molecular perspective. ANTIMICROB AGENTS CH , 46 (2) 267 - 274.

Gillespie, SH; (2002) Microbes sans frontieres. LANCET , 359 (9301) 93 - 95.

Gillespie, SH; (2002) Organisms of surgical importance. Surgery , 20 186 - 189.

Gillespie, SH; (2002) Treatment of skin infections. PRESCRIBER

Gillespie, SH; (2002) Migrating worms. In: Armstrong Cohen, J, (ed.) Infectious Diseases. Elsevier Science Press

Gillespie, SH; (2002) New quinolones for respiratory infections: mechanisms of action and resistance. (Royal Society of Medicine, Round Table Series 76 ). Royal Society of Medicine: London.

Gillespie, SH; Billington, OJ; Breathnach, A; McHugh, TD; (2002) Multiple drug resistant tuberculosis: evidence for changing fitness on passage through human hosts. Microbial Drug Resistance , 8 1 - 7.

Gillespie, SH; Billington, OJ; Breathnach, A; McHugh, TD; (2002) Multiple drug-resistant Mycobacterium tuberculosis: Evidence for changing fitness following passage through human hosts. MICROB DRUG RESIST , 8 (4) 273 - 279.

Gillespie, SH; Gosling, R; Charalambous, BM; (2002) A re-iterative method for calculating the early bactericidan activity of anti-tuberculosis drugs. American Journal of Respiratory and Critical Care Medicine , 166 (1) 31 - 35.

Gillespie, SH; Gosling, RD; Charalambous, BM; (2002) A reiterative method for calculating bactericidal activity of antituberculosis drugs. American Journal of Respiratory and Critical Care Medicine , 166 (1) 31 - 35.

Gillespie, SH; Gosling, RD; Charalambous, BM; (2002) A reiterative method for calculating the early bactericidal activity of antituberculosis drugs. AM J RESP CRIT CARE , 166 (1) 31 - 35. 10.1164/rccm.2112077.

Gillespie, SH; Tillotson, GS; (2002) Novel perspectives in antibacterial action. (Royal Society of Medicine, Round Table Series 76 ). Royal Society of Medicine

Gillespie, SH; Voelker, LL; Dickens, A; (2002) Evolutionary barriers to quinolone resistance in Streptococcus pneumoniae. MICROB DRUG RESIST , 8 (2) 79 - 84.

Grange, JM; Zumla, A; (2002) The global emergency of tuberculosis: what is the cause? J R SOC PROMO HEALTH , 122 (2) 78 - 81.

Grant, PR; Sims, CM; Krieg-Schneider, F; Love, EM; Eglin, R; Tedder, RS; (2002) Automated screening of blood donations for hepatitis C virus RNA using the Qiagen BioRobot 9604 and the Roche COBAS HCV Amplicor assay. VOX SANG , 82 (4) 169 - 176.

Grant, PR; Sims, CM; Tedder, RS; (2002) Quantification of HCV RNA levels and detection of core antigen in donations before seroconversion. TRANSFUSION , 42 (8) 1032 - 1036.

Griffiths, DJ; Voisset, C; Venables, PJW; Weiss, RA; (2002) Novel endogenous retrovirus in rabbits previously reported as human retrovirus 5. J VIROL , 76 (14) 7094 - 7102. 10.1128/JVI.76.14.7094-7102.2002.

Griffiths, PD; (2002) Benefits of bioterrorism. Reviews In Medical Virology , 12 (3) 131 - 132.

Griffiths, PD; (2002) Facilitating viral recombination. Reviews in Medical Virology , 12 (6) 335 - 336. 10.1002/rmv.374.

Griffiths, PD; (2002) Interactions between viral and human genes. Reviews In Medical Virology , 12 (4) 197 - 199.

Griffiths, PD; (2002) Opening the gates for vaccine development in the real world. Reviews in Medical Virology , 12 (2) 67 - 68. 10.1002/rmv.349.

Griffiths, PD; (2002) Preparing to treat prions. Reviews In Medical Virology , 12 (1) 1 - 3.

Griffiths, PD; (2002) Resistance in viruses other than HIV. Int J Infect Dis , 6 Suppl 1 S32 - S37.

Griffiths, PD; (2002) Strategies to prevent CMV infection in the neonate. Semin Neonatol , 7 (4) 293 - 299.

Griffiths, PD; (2002) The 2001 Garrod Lecture - The treatment of cytomegalovirus infection. J ANTIMICROB CHEMOTH , 49 (2) 243 - 253.

Griffiths, PD; (2002) The treatment of cytomegalovirus infection. Journal of Antimicrobial Chemotherapy , 49 (2) 243 - 253.

Griffiths, PD; (2002) Tomorrow's challenges for herpesvirus management: Potential applications of valacyclovir. JOURNAL OF INFECTIOUS DISEASES , 186 S131 - S137.

H

Hails, J; Kwaku, F; Wilson, APR; Bellingan, G; Singer, M; (2002) Large variation in MRSA policies, procedures, and prevalence in English intensive care units. A questionnaire analysis. BRIT J ANAESTH , 89 (2) 354P - 355P.

Hassan-Walker, AF; Emery, VC; Griffiths, PD; (2002) Molecular diagnosis of cytomegalovirus disease. In: Trull, A and Demers, LM and Holt, DW and Johnston, A and Tredger, JM and Price, CP, (eds.) BIOMARKERS OF DISEASE: AN EVIDENCE-BASED APPROACH. (pp. 467 - 473). CAMBRIDGE UNIV PRESS

Herrero-Martinez, E; Sabin, CA; Evans, JG; Griffioen, A; Lee, CA; Emery, VC; (2002) The prognostic value of a single hepatitis C virus RNA load measurement taken early after human immunodeficiency virus seroconversion. J INFECT DIS , 186 (4) 470 - 476.

Holzerlandt, R; Orengo, C; Kellam, P; Albà, MM; (2002) Identification of new herpesvirus gene homologs in the human genome. Genome Res , 12 (11) 1739 - 1748. 10.1101/gr.334302.

Huggett, JF; Mustafa, A; O'Neil, L; Mason, DJ; (2002) Does osteogenesis differentially regulate GLAST-1 and GLAST-1a? In: Bone. (pp. 6S - 6S).

I

Ikeda, Y; Collins, MKL; Radcliffe, PA; Mitrophanous, KA; Takeuchi, Y; (2002) Gene transduction efficiency in cells of different species by HIV and EIAV vectors. GENE THER , 9 (14) 932 - 938. 10.1038/sj.gt.3301708.

J

Jabs, DA; Griffiths, PD; (2002) Fomivirsen for the treatment of cytomegalovirus retinitis. AM J OPHTHALMOL , 133 (4) 552 - 556.

K

Kafwabulula, M; Ahmed, K; Nagatake, T; Gotoh, J; Mitarai, S; Oizumi, K; Zumla, A; (2002) Evaluation of PCR-based methods for the diagnosis of tuberculosis by identification of mycobacterial DNA in urine samples. INT J TUBERC LUNG D , 6 (8) 732 - 737.

Kafwabulula, M; Ahmed, K; Nagatake, T; Gotoh, J; Mitarai, S; Terunuma, H; Zumla, A; (2002) Evaluation of PCR-based methods for the diagnosis of tuberculosis by identification of mycobacterial DNA in urine samples. International Journal of Tuberculosis and Lung Disease , 6 (8) 1 - 6.

Kann, MG; Goldstein, RA; (2002) Performance evaluation of a new algorithm for the detection of remote homologs with sequence comparison. Proteins , 48 (2) 367 - 376. 10.1002/prot.10117.

Kasolo, F; Lishimpi, K; Chintu, C; Mwaba, P; Mudenda, V; Maswahu, D; ... Zumla, A; + view all (2002) Identification of Pneumocystis carinii DNA by polymerase chain reaction in necropsy lung samples from children dying of respiratory tract illnesses. J PEDIATR , 140 (3) 367 - 369. 10.1067/mpd.2002.122468.

Kellam, P; AlbÃ, MM; (2002) Virus bioinformatics: databases and recent applications. Applied Bioinformatics , 1 (1) 37 - 42.

Kellam, P; Mar Alba, M; (2002) Databases and recent applications. Applied Bioinformatics , 1 (1) 37 - 42.

Kellam, P; Xiaohui, L; Martin, NJ; Orengo, CA; Swift, S; Tucker, A; (2002) A framework for modelling virus gene expression data. Intelligent Data Analysis , 5 1 - 13.

Kinloch, SA; B,; (2002) HIV-1 therapeutic vaccines. Journal of INfection , 44 152 - 159.

Kunori, T; Cookson, B; Roberts, JA; Stone, S; Kibbler, C; (2002) Cost-effectiveness of different MRSA screening methods. J Hosp Infect , 51 (3) 189 - 200.

L

Leśnikowski, ZJ; Paradowska, E; Przepiórkiewicz, M; Olejniczak, A; Emery, VC; (2002) [Drugs against human cytomegalovirus]. Pol Merkur Lekarski , 13 (75) 242 - 249.

Lishimpi, K; Kasolo, F; Chintu, C; Mwaba, P; Mudenda, V; Maswahu, D; ... Zumla, A; + view all (2002) Identification of Pneumocystis carinii DNA in oropharyngeal mouth washes from AIDS children dying of respiratory illnesses. AIDS , 16 (6) 932 - 934.

Ljungman, P; Griffiths, P; Paya, C; (2002) Definitions of cytomegalovirus infection and disease in transplant recipients. CLIN INFECT DIS , 34 (8) 1094 - 1097.

Lock, MJ; Thorley, N; Teo, J; Emery, VC; (2002) Azidodeoxythymidine and didehydrodeoxythymidine as inhibitors and substrates of the human herpesvirus 8 thymidine kinase. J ANTIMICROB CHEMOTH , 49 (2) 359 - 366.

M

Maguire, H; Dale, JW; McHugh, TD; Butcher, PD; Gillespie, SH; Costetsos, A; ... Banerjee, DK; + view all (2002) Molecular epidemiology of tuberculosis in London 1995-7 showing low rate of active transmission. THORAX , 57 (7) 617 - 622.

Mason, DJ; Huggett, JF; (2002) Glutamate transporters in bone. Journal of Musculoskeletal and Neuronal Interactions , 2 (5) 406 - 414.

Mays, S; Fysh, E; Taylor, GM; (2002) Periostitic rib lesions – a sign of pulmonary tuberculosis? American Journal of Physical Anthropology , 119 (1) 27 - 36.

Mays, S; Taylor, GM; (2002) Osteological and biomolecular study of two possible cases of hypertrophic osteoarthropathy from Mediaeval England. Journal of Archaeological Science , 29 1267 - 1276.

McGregor, JM; Harwood, CA; Brooks, L; Fisher, SA; Kelly, DA; O'nions, J; ... Crook, T; + view all (2002) Relationship between p53 codon 72 polymorphism and susceptibility to sunburn and skin cancer. J INVEST DERMATOL , 119 (1) 84 - 90.

Mele, A; Paterson, PJ; Prentice, HG; Leoni, P; Kibbler, CC; (2002) Toxoplasmosis in bone marrow transplantation: a report of two cases and systematic review of the literature. BONE MARROW TRANSPL , 29 (8) 691 - 698. 10.1038/sj/bmt/1703425.

Mele, A; Paterson, PJ; Prentice, HG; Leoni, P; Kibbler, CC; (2002) Toxoplasmosis in bone marrow transplantation: a report of two cases and systematic review of the literature. Bone Marrow Transplant , 29 (8) 691 - 698. 10.1038/sj.bmt.1703425.

Melzer, M; Brown, TJ; French, GL; Dickens, A; McHugh, TD; Bagg, LR; ... Lacey, S; + view all (2002) Molecular analysis of drug resistant TB. THORAX , 57 (6) 562 - 563.

Mistry, NF; Iyer, AM; D souza, DTB; Taylor, GM; Young, DB; Antia, NH; (2002) Mycobacterium tuberculosis Isolates from Multiple-Drug-Resistant Tuberculosis Patients from Bombay, India. Journal of Clinical Microbiology , 40 2677 - 2680.

Morgan, JE; Gross, JG; Pagel, CN; Beauchamp, JR; Fassati, A; Thrasher, AJ; ... Partridge, TA; + view all (2002) Myogenic cell proliferation and generation of a reversible tumorigenic phenotype are triggered by preirradiation of the recipient site. J CELL BIOL , 157 (4) 693 - 702. 10.1083/jcb.200108047.

Muir, WB; Nichols, R; Breuer, J; (2002) Phylogenetic analysis of varicella-zoster virus: Evidence of intercontinental spread of genotypes and recombination. J VIROL , 76 (4) 1971 - 1979. 10.1128/JVI.76.4.1971-1979.2002.

Mwinga, A; Nunn, A; Ngwira, B; Chintu, C; Warndorff, D; Fine, P; ... LUSKAR Collaboration,; + view all (2002) Mycobacterium vaccae (SRL172) immunotherapy as an adjunct to standard antituberculosis treatment in HIV-infected adults with pulmonary tuberculosis: a randomised placebo-controlled trial. LANCET , 360 (9339) 1050 - 1055.

N

Nokta, MA; Holland, F; De Gruttola, V; Emery, VC; Jacobson, MA; Griffiths, P; ... Int CMV Prophylaxis Study Grp,; + view all (2002) Cytomegalovirus (CMV) polymerase chain reaction profiles in individuals with advanced human immunodeficiency virus infection: Relationship to CMV disease. J INFECT DIS , 185 (12) 1717 - 1722.

Nothdurft, HD; Dietrich, M; Zuckerman, JN; Knobloch, J; Kern, P; Vollmar, J; Sanger, R; (2002) A new accelerated vaccination schedule for rapid protection against hepatitis A and B. VACCINE , 20 (7-8) 1157 - 1162.

P

Paterson, DA; Dyer, AP; Milne, RSB; Sevilla-Reyes, E; Gompels, UA; (2002) A role for human cytomegalovirus glycoprotein O (gO) in cell fusion and a new hypervariable locus. VIROLOGY , 293 (2) 281 - 294. 10.1006/viro.2001.1274.

Perrin, L; Cooper, DA; Hoen, B; Kinloch, S; Phillips, A; Tsoukas, C; ... Sekaly, R; + view all (2002) Therapeutic vaccination in primary HIV infection, the Quest trial. Vaccine , 20 (15) 2004 - 2006. 10.1016/S0264-410X(02)00087-7.

Perrons, C; Kleter, B; Jelley, R; Jalal, H; Quint, W; Tedder, R; (2002) Detection and genotyping of human papillomavirus DNA by SPF10 and MY09/11 primers in cervical cells taken from women attending a colposcopy clinic. J Med Virol , 67 (2) 246 - 252. 10.1002/jmv.2214.

Phillips, AN; Staszewski, S; Lampe, F; Youle, MS; Klauke, S; Bickel, M; ... Royal Free Ctr HIV Med Goethe Univ,; + view all (2002) Human immunodeficiency virus rebound after suppression to < 400 copies/mL during initial highly active antiretroviral therapy regimens, according to prior nucleoside experience and duration of suppression. JOURNAL OF INFECTIOUS DISEASES , 186 (8) 1086 - 1091. Green open access
file

Pillay, D; Emery, VC; Mutimer, D; Ogilvie, MM; Carman, W; Mutton, K; ... Public Hlth Laboratory Service Adv,; + view all (2002) Guidelines for laboratory monitoring of treatment of persistent virus infections. J CLIN VIROL , 25 (1) 73 - 92.

Pillay, D; Walker, AS; Gibb, DM; de Rossi, A; Kaye, S; Ait-Khaled, M; ... Paediat European Network Treatment,; + view all (2002) Impact of human immunodeficiency virus type 1 subtypes on virologic response and emergence of drug resistance among children in the Paediatric European Network for Treatment of AIDS (PENTA) 5 trial. In: JOURNAL OF INFECTIOUS DISEASES. (pp. 617 - 625). UNIV CHICAGO PRESS

Q

Qian, B; Goldstein, RA; (2002) Optimization of a new score function for the generation of accurate alignments. Proteins , 48 (4) 605 - 610. 10.1002/prot.10132.

Quinlivan, M; Hawrami, K; Barrett-Muir, W; Aaby, P; Arvin, A; Chow, VT; ... Breuer, J; + view all (2002) The molecular epidemiology of varicella-zoster virus: Evidence for geographic segregation. JOURNAL OF INFECTIOUS DISEASES , 186 (7) 888 - 894.

R

Rook, GA; Brunet, LR; (2002) Give us this day our daily germs. Biologist (London) , 49 (4) 145 - 149.

Rook, GA; Lightman, SL; Heijnen, CJ; (2002) Can nerve damage disrupt neuroendocrine immune homeostasis? Leprosy as a case in point. Trends in Immunology , 23 (1) 18 - 22.

Rook, GAW; (2002) Immunoregulation: the hygiene hypothesis and the brain. In: Immunology. (pp. 40 - 40).

Rook, GAW; Lightman, SL; Heijnen, CJ; (2002) Can nerve damage disrupt neuroendocrine immune homeostasis? Leprosy as a case in point. TRENDS IMMUNOL , 23 (1) 18 - 22.

Rook, GAW; Rosa Brunet, L; Hunt, J; (2002) Multiple consequences of the changing educational input to our immune systems. In: Heidt, PJ and Midtvedt, T and Rusch, V and van der Waaij, D, (eds.) Probiotics: Bacteria and Bacterial Fragments as Immunomodulatory Agents. (35 - 53). Institut f+r Integrative Biologie GmbH: Herborn-Dill, Germany.

Ruddy, M; Kibbler, CC; (2002) Endoscopic decontamination: an audit and practical review. J HOSP INFECT , 50 (4) 261 - 268. 10.1053/jhin.2002.1177.

Ruddy, M; McHugh, TD; Dale, JW; Banerjee, D; Maguire, H; Wilson, P; ... Gillespie, SH; + view all (2002) Estimation of the rate of unrecognized cross-contamination with Mycobacterium tuberculosis in London microbiology laboratories. J CLIN MICROBIOL , 40 (11) 4100 - 4104. 10.1128/JCM.40.11.4100-4104.2002.

S

Sabin, CA; Emery, V; Devereux, HL; Griffioen, AA; Bishop, J; Dusheiko, G; ... Lee, CA; + view all (2002) Long-term patterns of hepatitis C virus RNA concentrations in a cohort of HIV seronegative men with bleeding disorders. J MED VIROL , 68 (1) 68 - 75. 10.1002/jmv.10171.

Sabin, CA; Griffioen, A; Yee, TT; Emery, VC; Herrero-Martinez, E; Phillips, AN; Lee, CA; (2002) Markers of HIV-1 disease progression in individuals with haemophilia coinfected with hepatitis C virus: a longitudinal study. LANCET , 360 (9345) 1546 - 1551.

Sadiq, ST; Taylor, S; Kaye, S; Bennett, J; Johnstone, R; Byrne, P; ... Weller, I; + view all (2002) The effects of antirectroviral therapy on HIV-1 RNA loads in seminal plasma in HIV positive patients with and without urethritis. AIDS , 16 (2) 219 - 255. 10.1097/00002030-200201250-00011.

Sadiq, ST; Taylor, S; Kaye, S; Bennett, J; Johnstone, R; Byrne, P; ... Weller, I; + view all (2002) The effects of antiretroviral therapy on HIV-1 RNA loads in seminal plasma in HIV-positive patients with and without urethritis. AIDS , 16 (2) 219 - 225.

Sharma, OP; Zumla, AI; (2002) Tropical lung disease. Clinics in Chest Medicine , 23 (2) 10.1016/S0272-5231(02)00006-0.

Shepherd, AJ; Martin, NJ; Johnson, RG; Kellam, P; Orengo, CA; (2002) PFDB: a generic protein family database integrating the CATH domain structure database with sequence based protein family resources. BIOINFORMATICS , 18 (12) 1666 - 1672.

Simmonds, P; Kurtz, J; Tedder, RS; (2002) Alternatives to nucleic acid testing in the blood transfusion service - Reply. LANCET , 360 (9344) 1519 - 1520.

Simmonds, P; Kurtz, J; Tedder, RS; (2002) The UK blood transfusion service: over a (patent) barrel? The Lancet , 359 (9319) 1713 - 1714.

Soyer, O; Dimmic, MW; Neubig, RR; Goldstein, RA; (2002) Using evolutionary methods to study G-protein coupled receptors. Pac Symp Biocomput 625 - 636.

Stansby, G; Chan, YC; Berwanger, CS; Shurey, S; Rook, GAW; Stanford, JL; (2002) Prevention of experimental myointimal hyperplasia by immunomodulation. EUR J VASC ENDOVASC , 23 (1) 23 - 28. 10.1053/ejvs.2001.1549.

Stringer, C; Chiodini, J; Zuckerman, JN; (2002) Continuing Professional Development in Travel Medicine. The Nursing Standard , 16 (39) 49 - 54.

T

Taverna, DM; Goldstein, RA; (2002) Why are proteins marginally stable? Proteins , 46 (1) 105 - 109.

Taverna, DM; Goldstein, RA; (2002) Why are proteins so robust to site mutations? J Mol Biol , 315 (3) 479 - 484. 10.1006/jmbi.2001.5226.

Tedder, RS; Ayliffe, U; Preiser, W; Brink, NS; Grant, PR; Peggs, KS; ... Garson, JA; + view all (2002) Development and evaluation of an internally controlled semiautomated PCR assay for quantification of cell-free cytomegalovirus. J MED VIROL , 66 (4) 518 - 523. 10.1002/jmv.2175.

Tedder, RS; Ijaz, S; Gilbert, N; Barbara, JAJ; Corden, SA; Gilson, RJC; Boxall, EH; (2002) Evidence for a dynamic host-para-site relationship in e-negative hepatitis B carriers. J MED VIROL , 68 (4) 505 - 512. 10.1002/jmv.10241.

Tilling, R; Kinloch, S; Goh, LE; Cooper, D; Perrin, L; Lampe, F; ... Quest Study Grp,; + view all (2002) Parallel decline of CD8+/CD38++ T cells and viraemia in response to quadruple highly active antiretroviral therapy in primary HIV infection. AIDS , 16 (4) 589 - 596.

Towers, G; Collins, M; Takeuchi, Y; (2002) Abrogation of Ref1 retrovirus restriction in human cells. J VIROL , 76 (5) 2548 - 2550. 10.1128/JVI.76.5.2548-2550.2002.

W

Walker, SJ; Pizzato, M; Takeuchi, Y; Devereux, S; (2002) Heparin binds to murine leukaemia virus and inhibits Env-independent attachment and infection. Journal of Virology , 76 6909 - 6918.

Wallace, SM; Walton, BI; Kharbanda, RK; Hardy, R; Wilson, AP; Swanton, RH; (2002) Mortality from infective endocarditis: clinical predictors of outcome. HEART , 88 (1) 53 - 60.

Weiss, RA; (2002) Hepatitis B - The hunt for a killer virus. SCIENCE , 297 (5590) 2213 - 2213.

Weiss, RA; (2002) HIV receptors and cellular tropism. IUBMB LIFE , 53 (4-5) 201 - 205. 10.1080/15216540290098927.

Weiss, RA; (2002) HIV receptors and cellular tropism. IUBMB Life , 53 (4-5) 201 - 205. 10.1080/15216540212652.

Weiss, RA; (2002) Reflections on the origin of human immunodeficiency viruses. AIDS and Hepatitis Digest , 87 2 - 4.

Weiss, RA; (2002) Virulence and pathogenesis. TRENDS MICROBIOL , 10 (7) 314 - 317.

Weiss, RA; (2002) Xenotransplantation: promise and problems. In: Brooks, G, (ed.) Gene Therapy: the use of DNA as a drug. (295 - 312). Pharmaceutical Press

Whalley, S; Brown, D; Webster, G; Jacobs, R; Teo, CG; Emery, V; Dusheiko, G; (2002) Evolution of hepatitis B virus during primary infection: Relevance to virulence and outcome. J HEPATOL , 36 95 - 95.

Whalley, SA; Brown, D; Webster, GJM; Jacobs, R; Teo, CG; Emery, VC; Dusheiko, GM; (2002) Evolution of hepatitis B virus during primary infection. GUT , 50 A118 - A118.

Whalley, SA; Webster, GJM; Brown, D; Teo, CG; Bertoletti, A; Emery, VC; Dusheiko, GM; (2002) Transient generation of core CD8+ cytotoxic T-cell escape mutants during primary HBV infection. GUT , 50 A112 - A112.

Whitehouse, T; Cepeda, J; Cooper, B; Hails, J; Jones, K; Kwaku, F; ... Singer, M; + view all (2002) Treatment of bacteraemia and LRTI with linezolid in the critically ill patient: a randomized double-blind comparison against teicoplanin. In: (Proceedings) 15th Annual Congress of the European Society of Intensive Care Medicine.. : Barcelona.

Whitehouse, T; Cepeda, J; Cooper, B; Hails, J; Jones, K; Kwaku, F; ... Singer, M; + view all (2002) Bacteraemia & LRTI treatment with linezolid in the critically ill: a randomized double-blind. In: INTENSIVE CARE MEDICINE. (pp. S70 - S70). SPRINGER-VERLAG

Whiting, GC; Evans, JT; Patel, S; Gillespie, SH; (2002) Purification of native alpha-enolase from Streptococcus pneumoniae that binds plasminogen and is immunogenic. J MED MICROBIOL , 51 (10) 837 - 843.

Wilkinson, J; Cope, A; Gill, J; Bourboulia, D; Hayes, P; Imami, N; ... Gotch, F; + view all (2002) Identification of Kaposi's sarcoma-associated herpesvirus (KSHV)-specific cytotoxic T-lymphocyte epitopes and evaluation of reconstitution of KSHV-specific responses in human immunodeficiency virus type 1-infected patients receiving highly active antiretr. Journal of Virology , 76 (6) 2634 - 2640.

Y

Yuan, B; Fassati, A; Yueh, A; Goff, SP; (2002) Characterization of Moloney murine leukemia virus p12 mutants blocked during early events of infection. J VIROL , 76 (21) 10801 - 10810. 10.1128/JVI.76.21.10801-10810.2002.

Z

Zgiby, S; Plater, AR; Bates, MA; Thomson, GJ; Berry, A; (2002) A functional role for a flexible loop containing Glu182 in the class II fructose-1,6-bisphosphate aldolase from Escherichia coli. J Mol Biol , 315 (2) 131 - 140. 10.1006/jmbi.2001.5237.

Zuany-Amorim, C; Manlius, C; Trifilieff, A; Brunet, LR; Rook, G; Bowen, G; ... Walker, C; + view all (2002) Long-term protective and antigen-specific effect of heat-killed Mycobacterium vaccae in a murine model of allergic pulmonary inflammation. J IMMUNOL , 169 (3) 1492 - 1499.

Zuany-Amorim, C; Sawicka, E; Manlius, C; Le Moine, AL; Brunet, LR; Kemeny, DM; ... Walker, C; + view all (2002) Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells. NAT MED , 8 (6) 625 - 629. 10.1038/nm0602-625.

Zuckerman, J; (2002) Recent Advances in Travel Medicine. BMJ (Clinical Research Ed.) , 325 260 - 264.

Zuckerman, JN; (2002) Clinical Review: Recent Advances in Travel Medicine. BMJ (Clinical Research Ed.) , 325 260 - 264.

Zuckerman, JN; (2002) Recent developments - Travel medicine. BRIT MED J , 325 (7358) 260 - 264.

Zuckerman, JN; (2002) Health and illness among airline passengers. In: Bor, R, (ed.) Passenger Behaviour. (232 - 246). Ashgate Publishing

Zuckerman, JN; (2002) Travel health advice for travellers with immunosuppressive disorders. In: Howarth-Wilson, J, (ed.) Bugs, Bowels & Bites. Cadogan Guides

Zuckerman, JN; (2002) A guide to the medical student elective abroad. In: Ryan, J and Greaves, I and Mahoney, P and Bowyer, G, (eds.) Handbook of Medicine in Hostile Environments. (131 - 141). Springer-Verlag London

Zuckerman, JN; (2002) International Travel and Health 2002. In: World, HO, (ed.) International Travel and Health 2002. (1 - 210). World Health Organisation

Zuckerman, JN; Zuckerman, AJ; (2002) Recombinant hepatitis B triple antigen vaccine: Hepacare. Expert Rev Vaccines , 1 (2) 141 - 144. 10.1586/14760584.1.2.141.

Zuckerman, JN; Zuckerman, AJ; (2002) Viral Hepatitis. In: Cook, GC and Zumla, A, (eds.) Manson’s Tropical Diseases. (707 - 725). Harcourt International

Zuckerman, JN; Zuckerman, AJ; (2002) Viral hepatitis. In: Dawood, R, (ed.) Travellers' Health. (54 - 62). Oxford University Press

Zuckerman, JN; Zuckerman, AJ; (2002) Molecular Epidemiology of Hepatitis B virus. In: Leitner, T, (ed.) The Molecualr Epidemiology of Human Viruses. (401 - 419). Kluwer Academic Publishers

Zumla, A; (2002) Betrayal of trust. Journal of the Royal Society of Medicine , 95 (6) 319 - 320.

Zumla, A; (2002) Drugs for neglected diseases. LANCET INFECT DIS , 2 (7) 393 - 393.

Zumla, A; (2002) Editorial overview: infectious diseases. CURR OPIN PULM MED , 8 (3) 151 - 153.

ZUMLA, A; (2002) Tropical Lung Diseases CLINICS IN CHEST MEDICINE. CLINICS IN CHEST MEDICINE: Vol.23 NO 2.

Zumla, A; Costello, A; (2002) Ethics of healthcare research in developing countries. J ROY SOC MED , 95 (6) 275 - 276.

Zumla, A; Grange, J; (2002) Infection and disease caused by environmental mycobacteria. CURR OPIN PULM MED , 8 (3) 166 - 172.

Zumla, AI; Grange, J; (2002) Non-tuberculous mycobacterial pulmonary infections. CLINICS IN CHEST MEDICINE , 23 (2) , Article PII S0272-5231(01)00011-9. 10.1016/S0272-5231(01)00011-9.

Zumla, AI; James, DG; (2002) Immunologic aspects of tropical lung disease. Clinics in Chest Medicine , 23 (2) 283 - 308. 10.1016/S0272-5231(01)00005-3.

This list was generated on Sun Jul 27 16:39:39 2014 BST.